WILMINGTON – Seeking to supercharge its cancer drug pipeline, pharmaceutical giant AstraZeneca announced a deal potentially worth more than $1.2 billion to acquire a small California-based biotech firm working on […]
WILMINGTON – The global pharmaceutical giant AstraZeneca recently informed employees that it is pursuing a buyout of its $1.3 billion pension plan for U.S. employees by a third-party insurer, likely […]
WILMINGTON – Pharmaceutical giant AstraZeneca has signed two separate global development and commercialization agreements for drugs that treat a protein disease, signaling that the firm sees the patient segment as […]
WILMINGTON – Pharmaceutical giant AstraZeneca sold the rights to two of its drugs used in the treatment of chronic obstructive pulmonary disease (COPD) for $270 million, the company announced Nov. […]
WILMINGTON — AstraZeneca has donated $25,000 to the Delaware Breast Cancer Coalition on Nov. 1 as part of its inaugural “ACT on Health Equity: Community Solutions Challenge.” The biopharmaceutical […]
WILMINGTON – Pharmaceutical giant AstraZeneca has acquired Caelum Biosciences, a small clinical-stage biotechnology company, for $150 million. The New Jersey-based Caelum was founded by New York-based biopharma company Fortress Biotech […]
WILMINGTON – The pharmaceutical giant AstraZeneca announced Saturday that it has reached an agreement to acquire rare disease specialist Alexion Pharmaceuticals Inc. for $39 billion, the largest industry deal this […]
WILMINGTON – AstraZeneca reported Monday morning that its COVID-19 vaccine has shown an average 70% efficacy rate, with potential for up to 90%, giving further confidence to the public that […]
WILMINGTON – Building on its work toward a COVID-19 vaccine, the pharmaceutical giant AstraZeneca announced Tuesday morning that it has secured federal funding for a treatment using antibodies grown in […]
WILMINGTON – Pharmaceutical giant AstraZeneca announced May 21 that it will receive upward of $1.2 billion from the federal government to advance work on its COVID-19 vaccine. The Cambridge-based company, […]
John Haydon has put a face on the power of social media and on the willingness of pharmaceutical companies to support patients to deal with the high cost of their […]
AstraZeneca last week announced the approval by the U.S. Food and Drug Administration of IMFINZI. The drug treats Stage III non-small cell lung cancer. “The approval of IMFINZI in this […]
Fasenra, AstraZeneca’s add-on maintenance treatment for patients with severe asthma, has received U.S. Food and Drug Administration approval. Fasenra is approved for patients 12 and older with an eosinophilic phenotype, […]
Incyte and AstraZeneca will expand their clinical collaboration and evaluate how Incyte’s apacadostat and AstraZeneca’s Imfinzi work in combination, compared with Imfinzi alone. Apacadostat is Incyte’s investigational selective IDO1 enzyme […]
Capital One announced today a $46.3 million bridge loan to Brandywine Investment Group towards the acquisition of the AstraZeneca North Campus in Wilmington. Brandywine Investment Group first acquired the property […]
WILMINGTON – The U. S Food and Drug Administration has granted approval to Lynparza, AstraZeneca and Merck’s PARP inhibitor for maintenance therapy for some ovarian cancer patients, according to the […]
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Imfinzi, an experimental drug developed by AstraZeneca and MedImmune. The drug is used for the treatment of […]
LONDON (AP) – Shares in Anglo-Swedish drugmaker AstraZeneca plunged as much as 17 percent Thursday after a new lung cancer treatment proved less successful than the company had hoped. AstraZeneca […]
Professor Nazneen Rahman today joined the Board of Directors and Science Committee at AstraZeneca. Rahman is head of the Divison of Genetics and Epidemiology at the Institute of Cancer Research […]
AstraZeneca is notifying physicians and consumers of its voluntary recall of sample bottles of Brilinta 90 mg tablets given to physicians. The recall is a precautionary measure following a report […]
Premier Digital Partners
© 2022 Delaware Business Times
p>